Engineered hybrid cell membrane nanovesicles for potentiated cancer immunotherapy through dual immune checkpoint inhibition DOI

Fuxu Yang,

Xue Han, Yuxin Fan

и другие.

Biomaterials Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

In this study, we developed a PD-1/LAG-3 receptors-decorated cell membrane nanovesicle for combination immunotherapy in colorectal cancer. The hybrid substantially inhibited tumor growth and elicited robust antitumor immune response MC38 xenograft-bearing mice.

Язык: Английский

Exploring the application of metal-based photothermal agents in photothermal therapy combined with immune checkpoint therapy DOI Creative Commons
Bin Xie, Zunqiang Xiao,

Jiabao Ling

и другие.

Frontiers in Pharmacology, Год журнала: 2025, Номер 16

Опубликована: Фев. 13, 2025

Photothermal therapy (PTT), a popular local treatment that uses heat to ablate tumors, has limited efficacy in addressing metastatic and deeply located tumors when used alone. Integrating PTT with immunotherapy not only yields synergistic effect but also promotes cancer regression confers the benefit of immune memory, which can surmount challenges faced by isolation. Metal-based nanomaterials, renowned for their superior photothermal conversion efficiency distinctive photochemical properties, have been extensively researched applied field PTT. This review summarizes latest developments combination therapies, specific focus on checkpoint (ICT) treatment, including comprehensive overview recent advancements noble metal-based 2D transition metal chalcogenides (TMDCs)-based agents, anticancer combining blockades (anti-CTLA-4 anti-PD-L1) therapy. The goal this is present an application, current future prospects agents combined ICT treatment.

Язык: Английский

Процитировано

0

Engineered hybrid cell membrane nanovesicles for potentiated cancer immunotherapy through dual immune checkpoint inhibition DOI

Fuxu Yang,

Xue Han, Yuxin Fan

и другие.

Biomaterials Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

In this study, we developed a PD-1/LAG-3 receptors-decorated cell membrane nanovesicle for combination immunotherapy in colorectal cancer. The hybrid substantially inhibited tumor growth and elicited robust antitumor immune response MC38 xenograft-bearing mice.

Язык: Английский

Процитировано

0